Table 1 Characteristic of participants.
From: Neutrophil-to-lymphocyte ratio as a predictor of cardiovascular mortality in cancer survivors
Characteristics | Lower NLR (n = 3138) | Higher NLR (n = 1836) | P value |
|---|---|---|---|
Estimated N | 13,881,246 | 7,375,381 | |
NLR | 1.77 (0.49) | 3.85 (1.58) | < 0.001 |
Neutrophils (1000 cells/μL) | 3.83 (1.34) | 5.39 (1.79) | < 0.001 |
Lymphocyte (1000 cells/μL) | 2.47 (1.85) | 1.48 (0.51) | < 0.001 |
Age (year) | 60.66 (14.81) | 66.03 (14.14) | < 0.001 |
BMI (kg/m2) | 28.71 (6.25) | 28.72 (6.60) | 0.962 |
Gender (%) | < 0.001 | ||
Male | 37.9% | 48.9% | |
Female | 62.1% | 51.1% | |
Race/ethnicity | 0.001 | ||
Mexican American | 2.6% | 1.8% | |
Non Hispanic White | 85.5% | 89.2% | |
Non Hispanic Black | 5.8% | 3.9% | |
Other Race | 6.1% | 5.1% | |
Education level | 0.865 | ||
Less than High school | 14.7% | 14.8% | |
High school | 22.3% | 23.7% | |
Some college or associate degree | 31.1% | 30.5% | |
College graduate or above | 31.8% | 31.0% | |
Married state | 0.034 | ||
Never married/widowed/divorced/separated | 32.4% | 36.9% | |
Married/living with partner | 67.6% | 63.1% | |
Smoke history | 0.120 | ||
Ever | 53.6% | 56.4% | |
Never | 46.4% | 43.6% | |
Ratio of family income to poverty level | < 0.001 | ||
< 1 | 9.2% | 8.2% | |
1–3 | 37.2% | 45.1% | |
> 3 | 53.6% | 46.7% | |
Pre-exist comorbidities | |||
HF (%) | < 0.001 | ||
Yes | 4.6% | 9.8% | |
No | 95.4% | 90.2% | |
CHD (%) | < 0.001 | ||
Yes | 6.6% | 10.6% | |
No | 93.4% | 89.4% | |
Stroke (%) | 0.007 | ||
Yes | 5.7% | 8.6% | |
No | 94.3% | 91.4% | |
Diabetes (%) | 0.001 | ||
Yes | 13.9% | 18.4% | |
No | 86.1% | 81.6% | |
HBP | < 0.001 | ||
Yes | 47.6% | 56.7% | |
No | 52.4% | 43.3% | |
High cholesterol (%) | 0.755 | ||
Yes | 47.8% | 48.4% | |
No | 52.2% | 51.6% | |
Chronic bronchitis (%) | 0.922 | ||
Yes | 11.1% | 11.2% | |
No | 88.9% | 88.8% | |
Liver condition (%) | 0.971 | ||
Yes | 5.4% | 5.2% | |
No | 94.6% | 94.8% | |
Cancer type | < 0.001 | ||
Non-melanoma skin | 30.0% | 26.8% | |
Breast | 13.9% | 17.3% | |
Cervix | 9.3% | 6.5% | |
Prostate | 8.2% | 11.4% | |
Melanoma | 8.0% | 7.4% | |
Colon | 4.5% | 4.4% | |
Uterus | 4.2% | 2.3% | |
Ovary | 2.5% | 1.1% | |
Lymphoma | 2.4% | 2.1% | |
Thyroid | 2.3% | 1.9% | |
Bladder | 1.6% | 1.9% | |
Kidney | 1.3% | 1.3% | |
Lung | 1.2% | 3.0% | |
Testis | 1.2% | 1.1% | |
Leukemia | 1.0% | 0.6% | |
Stomach | 0.6% | 0.2% | |
Bone | 0.5% | 0.4% | |
Liver | 0.5% | 0.2% | |
Brain | 0.4% | 0.2% | |
Mouth | 0.4% | 1.1% | |
Esophagus | 0.3% | 0.4% | |
Rectum | 0.3% | 0.6% | |
Soft tissue | 0.3% | 0.3% | |
Larynx | 0.2% | 0.8% | |
Blood | 0.1% | 0.3% | |
Other type | 5.0% | 6.2% | |
